Paper Details

  1. Home
  2. Paper Details

Four years' treatment efficacy of patients with severe hyperlipidemia. Lipid lowering drugs versus LDL-apheresis.

Author: BambauerR, MüllerU A, SchielR

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

LDL-apheresis was more effective than diet and drug therapy in lowering lipid levels in patients with hyperlipidemia, and was associated with improved clinical performance but lower psychological well-being.
Paper Details　
Original Abstract of the Article :
A total of 47 patients suffering from heterozygous hyperlipidemia were treated with LDL-apheresis (24 patients, aged 49.5 +/- 11.5 years), diet and/or lipid-lowering drugs or with diet and lipid-lowering drugs only (23 patients, aged 48.0 +/- 11.9 years). After treatment periods of 44.4 +/- 14.3 (ap...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/8964646

データ提供：米国国立医学図書館（NLM）

Lipid-Lowering Therapies: A Race Across the Desert of Hyperlipidemia

This study explores the effectiveness of lipid-lowering drugs versus LDL-apheresis in treating patients with severe hyperlipidemia. Imagine a race across a vast desert, with each participant using different strategies to reach the finish line. This research investigates two different approaches to combatting high cholesterol levels.

LDL-Apheresis: A Speedier Path Through the Desert

The study compared the outcomes of 24 patients treated with LDL-apheresis, a procedure that removes LDL cholesterol from the blood, to 23 patients treated with diet and lipid-lowering drugs. The results showed that LDL-apheresis was significantly more effective in lowering cholesterol levels, triglycerides, and the LDL/HDL ratio. This is like having a fast camel that can cover the distance quickly, while other camels have to rely on slower but steady methods. The study highlights the potential advantages of LDL-apheresis for those with severe hyperlipidemia.

Lipid-Lowering Therapies: A Race for Heart Health

The study underscores the importance of effective lipid-lowering therapies for preventing and managing cardiovascular disease. It's like providing the camels with the right nourishment and support for their journey across the desert. While LDL-apheresis appears to be more effective in lowering cholesterol levels, the choice of treatment should be based on individual needs, risk factors, and lifestyle considerations. It's important to work with a healthcare professional to develop a personalized plan that promotes long-term heart health.

Dr.Camel's Conclusion

This study explores the different paths to combatting hyperlipidemia, highlighting the effectiveness of LDL-apheresis compared to traditional drug therapy. It's like a race across the desert, with each camel choosing a different route to the finish line of better heart health. The choice of treatment should be based on individual circumstances, and it's always advisable to consult with a healthcare professional to determine the most suitable strategy for managing your lipid levels.

Date :
  1. Date Completed 1996-12-05
  2. Date Revised 2017-12-06
Further Info :

Pubmed ID

8964646

DOI: Digital Object Identifier

8964646

Related Literature

Article Analysis
・Side Effects of cholestyramine resin
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.